DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» PGRMC1
PGRMC1
Insulin Receptor Plasma Membrane Levels Increased by the Progesterone Receptor Membrane Component 1 S
PGRMC1 and PGRMC2 in Uterine Physiology and Disease
Loss of PGRMC1 Delays the Progression of Hepatocellular Carcinoma Via Suppression of Pro-Inflammatory Immune Responses
P338. Does Norethisterone Stimulate Human Breast Cancer Cells Proliferation by Promoting PGRMC1 Expression?
Progesterone Receptor Membrane Component 1 Suppresses the P53
PGRMC1 Phosphorylation Status and Cell Plasticity 1: Glucose Metabolism, Mitochondria
The Evolutionary Appearance of Signaling Motifs in PGRMC1
Triple a Patient Cells Suffering from Mitotic Defects Fail to Localize PGRMC1 to Mitotic Kinetochore Fibers
Microrna-181A Suppresses Progestin-Stimulated Breast Cancer
Insights Into the Mechanism of Action of 13-Cis Retinoic Acid
Progesterone Receptor Membrane Component-1 Regulates Hepcidin Biosynthesis
Progesterone Inhibits Apoptosis in Part by PGRMC1-Regulated Gene Expression
PGRMC Proteins Are Coming of Age: a Special Issue on the Role of PGRMC1 and PGRMC2 in Metabolism and Cancer Biology
Progesterone-Induced Activation of Membrane-Bound Progesterone Receptors in Murine Macrophage Cells
Interactions Between Progesterone and Tumor Necrosis Factor-A in the Regulation of Primordial Follicle Assembly
Progestogens in Singleton Gestations with Preterm Prelabor Rupture Of
PGRMC1 Localization and Putative Function in the Nucleolus of Bovine Granulosa Cells and Oocytes Authors and Affiliati
New Insight on a Possible Mechanism of Progestogens in Terms of Breast Cancer Risk
Top View
Review Article Progesterone and Related Compounds in Hepatocellular Carcinoma: Basic and Clinical Aspects
Progesterone Receptor Membrane Component 1 (Pgrmc1) Inhibits the Activity of Drug-Metabolizing Cytochromes P450 and Binds To
We Have Some Trouble with Special Characters and Displaying Monographs. 22.09.2018 ATC Code: G03FA17 Classification
Conditional Ablation of Progesterone Receptor Membrane Component 2
Hormone Response in Ovarian Cancer: Time to Reconsider As a Clinical Target?
Identification of the PGRMC1 Protein Complex As the Putative Sigma-2 Receptor Binding Site
Endometrial Decidualization: the Primary Driver of Pregnancy Health
Putative Genes and Pathways Involved in the Acne Treatment of Isotretinoin Via Microarray Data Analyses
Original Article Expression of PGRMC1 in Paraffin-Embedded Tissues of Breast Cancer
Reproductionreview
Book of Abstracts of Gynecological Endocrinology the 19Th World Congress
Progesterone Receptor Membrane Component 1 Is Phosphorylated Upon Progestin Treatment in Breast Cancer Cells
The Role of Progesterone Receptor Membrane Component 1 in Receptor Trafficking and Disease
Placenta 79 (2019) 46–52
Review Article Progesterone and Related Compounds in Hepatocellular Carcinoma: Basic and Clinical Aspects
Expression of Progesterone and Androgen Receptors in the Breast
PGRMC1 Inhibits Progesterone-Evoked Proliferation and Ca2+ Entry Via STIM2 in MDA-MB-231 Cells
Progesterone Increases Blood Glucose Via Hepatic Progesterone Receptor Membrane Component 1 Under Limited Or Impaired Action of Insulin Sang R
The Presence of Membrane-Bound Progesterone Receptor Induces Growth of Breast Cancer with Norethisterone but Not with Progesterone: a Xenograft Model
Study Design
Progesterone-Related Immune Modulation of Pregnancy and Labor
The Relationship Between Follicle Development and Progesterone Receptor Membrane Component-1 Expression in Women Undergoing in Vitro Fertilization
Estrogens Modulate Progesterone Receptor Expression and May Contribute to Progesterone- Mediated Apoptotic Β-Cell Death
Progestins Related to Progesterone and Testosterone Elicit Divergent Human Endometrial Transcriptomes and Biofunctions
Potential Applications for Sigma Receptor Ligands in Cancer Diagnosis and Therapy☆
Progesterone Receptor Membrane Component 1 Regulates Lipid
Glycyrrhizin Derivatives Suppress Cancer Chemoresistance by Inhibiting Progesterone Receptor Membrane Component 1
Therapeutic Advances in Regulating the Hepcidin/Ferroportin Axis